Kheir Al-Zouhayli
Neurology with Special Qualifications in Child Neurology · Troy, MINPI 1275607533
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,660 of the $32,364 with a category attached, or 63.8%. 26 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 55.7% of the total. Reporting peaked in 2021 at $18,107 and has fallen 89.7% since, to $1,858 in 2025. Among neurology with special qualifications in child neurology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 389 payments — averaging $83.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$18K
- Ironshore Pharmaceuticals Inc.$7K
- Eisai Inc.$2K
- Neurelis, Inc.$1K
- Catalyst Pharmaceuticals, Inc.$842
- UCB, Inc.$835
- plus $3K from 20 others
What the payments were for
- Speaking & faculty fees$20,66064%
- Travel & lodging$1,2454%
- Food & beverage$10,42432%
- Education$360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 104 | $18,014 |
| Ironshore Pharmaceuticals Inc. | 44 | $6,685 |
| Eisai Inc. | 42 | $1,881 |
| Neurelis, Inc. | 26 | $1,098 |
| Catalyst Pharmaceuticals, Inc. | 26 | $842 |
| UCB, Inc. | 38 | $835 |
| Corium, LLC | 24 | $666 |
| Collegium Pharmaceutical, Inc. | 12 | $429 |
| Sunovion Pharmaceuticals Inc. | 15 | $374 |
| Aquestive Therapeutics, Inc. | 13 | $262 |
| Noven Pharmaceuticals, Inc. | 2 | $249 |
| Amgen | 1 | $164 |
| Noven Therapeutics, LLC | 7 | $150 |
| Greenwich Biosciences, Inc. | 4 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $120 |
| Adlon Therapeutics L.p. | 6 | $119 |
| Tris Pharma Inc | 4 | $67 |
| Shire North American Group Inc | 3 | $66 |
| Aucta Pharmaceuticals, Inc. | 3 | $66 |
| Neos Therapeutics, LP | 3 | $41 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Avion Pharmaceuticals | 1 | $20 |
| Livanova USA, Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Zogenix Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$32,364 in reported general payments places this provider in the 90th percentile of 62 neurology with special qualifications in child neurology providers in Michigan.
See all neurology with special qualifications in child neurology providers in Michigan →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluoxetine Hcl | 12 | $2,437 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $794 |
| Divalproex Sodium | 12 | $243 |
| Aripiprazole | 13 | $125 |
| Modafinil | 11 | $84 |
| Risperidone | 11 | $66 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Troy
- Suad KhalilEast Lansing$146K
- Gyula AcsadiDetroit$86K
- Daniel ArndtWest Bloomfield$62K
- Michelle FigueroaDetroit$57K
- Christopher AllenSaginaw$38K
- Jena KruegerGrand Rapids$22K
- Seth DevriesGrand Rapids$14K
- Aimee LuatDetroit$12K
- Danielle NolanRoyal Oak$7K
- Eishi AsanoDetroit$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.